Zelluna Immunotherapy
Developing allogeneic TCR-NK therapies for solid tumors
Norway
25 employees
Venture round
Total: $7.50M
Biotechnology, Health Care +1
General Information
Norway
BounceWatch is an independent company data service, not affiliated with Zelluna Immunotherapy. To contact Zelluna Immunotherapy, visit zelluna.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Zelluna Immunotherapy compare?
A PDF of Zelluna Immunotherapy and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Zelluna Immunotherapy soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
Norway Market
Biotechnology
About Zelluna Immunotherapy
Business keywords: Immunotherapy, Cancer treatment, Adoptive cell therapy, T cell receptor technologies, Solid tumors, Biopharmaceutical, Cellular therapy, Allogeneic TCR-NK therapies, GMP facilities, Oslo Cancer Cluster, Norwegian Radium Hospital, Research and development, Immunooncology, Norwegian biotechnology
Funding Rounds & Investors (4)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | Undisclosed | 1 |
|
25 Aug 2022 |
| Venture Round | €7.50M | - |
|
11 Jun 2020 |
| Grant | Undisclosed | - |
|
11 Jun 2020 |
| Seed Round | Undisclosed | 1 |
|
01 Jan 2017 |
Zelluna Immunotherapy Alternatives & Competitors
View All Alternatives
A clinical stage oncology company developing personalised medicine approaches to cancer; cellular &...
Attacking solid tumors with TCRs
3T is an immunotherapy company developing next-generation, transformative therapies for broad patien...
FAQ About Zelluna Immunotherapy
Source: BounceWatch company record for Zelluna Immunotherapy, https://bouncewatch.com/company/zelluna, updated 14 November 2024. When citing, please name BounceWatch and link this page.
